Physician profile
Everett E Ferradino
NPI 1558554139
$495.82
in general payments reported to CMS, 2019-2025
11 companies · $34.85 in 2025
The $34.85 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.23 · 2020: $48.49 · 2021: $164 · 2022: $56.75 · 2023: $64.93 · 2024: $69.81 · 2025: $34.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $169.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $172.24 | 2021-2024 | Viaflow |
| Zimmer Biomet Holdings, INC. | $56.75 | 2022 | |
| Smith+Nephew, INC. | $53.33 | 2021-2025 | Grafix Pl |
| Medtronic USA, INC. | $50.63 | 2019-2020 | |
| Depuy Synthes Sales INC. | $30.00 | 2019 | |
| Paragon 28, INC. | $26.21 | 2020-2021 | |
| Bioventus LLC | $24.81 | 2024 | Exogen Ultrasound Bone Healing System |
| Rock Medical Orthopedics, INC. | $23.98 | 2023 | |
| Horizon Therapeutics Plc | $23.55 | 2019-2021 | |
| Integra Lifesciences Corporation | $18.87 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paratek Pharmaceuticals, INC. | $15.45 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Everett Ferradino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.